How Better Data Fosters Health Equity w/ Kirsten Axelsen

If we want data and clinical trials that meaningfully represent the population of people who take the drug, we’ll need to do more than just issue guides.In this episode, we interview returning guest Kirsten Axelsen,Senior Advisor for Charles River Associates, about making medicine more accessible to lower income people and creating a more equitable health system with better data.Join us as we discuss:The detrimental effects of price controls on early life stages of drug developmentWhy a price control on one is a price control on allThe deep concerns about health disparity and equityHow data can address racism, ageism, and poverty in health systems2022 as the year of the non-COVID vaccineCheck out these resources we mentioned:Report referenced at 1:16 here and here.Build Back Better Act As we continue this journey together, we want to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.